Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations

Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations

A new generation of active nanotherapeutic formulations employing genetically engineered interleukin1 receptor antagonist (IL1ra) protein complexes is developed through non‐covalent supramolecular as…

Read More…

You May Also Like